Circular Genomics Announces Formation of its Commercial Advisory Board with Veteran Industry Leaders [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
SAN DIEGO June 18, 2025 /PRNewswire/ -- Circular Genomics, Inc. , a global leader in circular RNA (circRNA) biomarkers for precision neurology and psychiatry, today announced the formation of a Commercial Advisory Board (CAB), which will support the company's efforts to bring its circRNA-driven precision medicine tools to market. The inaugural CAB will work closely with Circular Genomics' leadership team to provide commercial insights and strategic guidance as the company advances its pipeline of circRNA biomarker programs. The CAB's insights will help guide Circular Genomics in translating scientific innovation into real-world impact for patients suffering from debilitating chronic diseases such as Alzheimer's disease and other neurological and psychiatric disorders. "We are thrilled and honored to welcome such industry leaders to our Commercial Advisory Board as we advance and broaden our pipeline of precision neurology and psychiatry diagnostics," said Sami Shihabi , Chief Comme
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Is DTC pharma advertising coming to an end? [Yahoo! Finance]Yahoo! Finance
- Adam Parker of Trivariate Research Recommends Eli Lilly's Dividend as a Defensive Play [Yahoo! Finance]Yahoo! Finance
- Solar stocks, Eli Lilly & Verve, PureCycle: Trending Tickers [Yahoo! Finance]Yahoo! Finance
- Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular riskPR Newswire
- Eli Lilly CFO's on-stage comment shows the high stakes of public speaking: Trial Balance [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 5/1/25 - Miss
LLY
Sec Filings
- 6/17/25 - Form 4
- 6/17/25 - Form 4
- 6/17/25 - Form 4
- LLY's page on the SEC website